Aptive Welcomes Clive Ballard as Vice President of Enterprise Health Solutions
Aptive today announced the appointment of Clive Ballard, MSPM, as Vice President, Enterprise Health Solutions. Mr. Ballard joins Aptive at time of significant transformation throughout the health care environment, from changes to health system design and operations, to new modes of patient care delivery. Mr. Ballard is responsible for the continued advancement of Aptive’s health services and will provide strategic direction to government health programs to ensure Aptive’s cutting-edge client solutions remain firmly focused on patient-centered outcomes.
With almost 20 years of commercial and federal management consulting experience, Mr. Ballard brings a wealth of experience in the design, planning and implementation of strategic plans, management system frameworks and other mechanisms focused on continual improvement, mission enhancement, and operational efficiency—particularly in the health care and hospital settings. Through his work with numerous federal clients, Mr. Ballard has led delivery and served as a technical advisor for national strategy, policy and guidance; program evaluation and performance measurement; multi-stakeholder working groups and technical advisory committee facilitation; and enterprise-wide program implementation efforts.
"Clive is an inspirational, dedicated, people-centric leader with a remarkable scope of experience," said Jason Ormsby, PhD, Chief Healthcare Innovation Officer. "His ability to identify creative solutions and his genuine care for delivering quality patient outcomes will continue to be enormous assets, benefitting our clients, providers and our business."
Prior to joining Aptive, Mr. Ballard was a Senior Manager in Deloitte’s Operations Transformation practice, leading efforts across federal health accounts and within the Quality, Safety and Improvement Offering. He holds a Master’s degree in Project Management from The George Washington University and a Bachelor’s degree in Biological Sciences from the University of Edinburgh.